Business Context and Reporting Period
This Form 8-K Current Report was filed by Accuray Incorporated on February 2, 2011. The filing discloses the execution of an amended and restated employment letter with Euan S. Thomson, the Company's President and Chief Executive Officer. The agreement establishes a two-year term commencing January 1, 2011, and updates compensation and severance provisions.
Key Financial Metrics
The filing does not provide revenue, profit, cash flow, margin, debt, or liquidity metrics. It focuses exclusively on executive compensation terms.
- Base Salary: $512,500 annually.
- Target Annual Bonus: 100% of base salary ($512,500), contingent on performance criteria.
- Equity Grants: Annual stock options for 40,000 shares (subject to Board approval) and eligibility for Restricted Stock Units (RSUs).
- Vesting Schedule: Options vest monthly at 1/48th of the grant; RSUs vest 25% annually over four years.
Material Changes Versus Prior Period
The new Employment Letter amends and restates the prior agreement in its entirety. Key changes include:
- Employment Term: The prior agreement had no fixed term; the new agreement establishes a two-year term.
- Change in Control Trigger: The prior agreement utilized a "single-trigger" mechanism for payments upon a change in control. The new agreement requires a "double-trigger," necessitating both a change in control and a subsequent separation from service to qualify for enhanced severance.
Guidance, Outlook, and Risks
The filing contains no financial guidance or outlook. It details specific severance contingencies and risks related to executive retention and potential payouts:
- Standard Severance: Upon termination without cause or for "good reason" (outside of a change in control), Dr. Thomson is entitled to 12 months of base salary, 100% of the target bonus, 12 months of health benefits, and accelerated vesting of equity that would have vested over the next 12 months.
- Change in Control Severance: If a change in control occurs followed by a qualifying separation, Dr. Thomson is entitled to 24 months of base salary, 200% of the target bonus, 24 months of health benefits, and full immediate vesting of all outstanding options and RSUs.
- Tax Provisions: Payments may be delayed up to six months to comply with Section 409A of the Internal Revenue Code. Benefits may be reduced to avoid excise taxes under Section 4999 if the reduction results in a higher net after-tax benefit for the executive.
- Restrictive Covenants: Includes confidentiality, non-solicitation (one year post-employment), and non-competition (during employment) clauses.
Important Facts for Investor Verification
- Verify the total potential cash and equity payout obligations under the "double-trigger" change in control scenario.
- Confirm the specific performance criteria required to achieve the 100% target annual bonus.
- Review the full text of the Employment Letter when filed as an exhibit to the Form 10-Q for the quarter ended March 31, 2011, for complete legal definitions of "cause," "good reason," and "change in control."
- Assess the impact of the new two-year term on executive stability compared to the previous at-will arrangement.